title: [Drug access in poor countries].
abstract: As a responsible player in the global pharmaceutical industry, Sanofi-Aventis recognizes its special responsibility to provide poor countries with access to drugs and vaccines. This is a key component of the Group's approach to sustainable development. As such, the Access to Medicines department draws on Sanofi-Aventis' expertise in order to address major public health issues, starting with the treatment of malaria, tuberculosis, sleeping sickness, leishmaniasis and epilepsy, as well as access to vaccines. The department has four main activities: research and development of new drugs; improvement of existing treatments; information, communication and education of patients and healthcare professionals; and development of a differential pricing and distribution policy adapted to patients' income, with a "no profit-no loss" equilibrium.
authors.affiliation: Accès aux médicaments, Sanofi-Aventis.
authors.forename: Robert
authors.initials: R
authors.lastname: Sebbag
mesh_terms: D003906:Developing Countries; D004345:Drug Industry; D006297:Health Services Accessibility; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D011203:Poverty
chemical_list: D004364:Pharmaceutical Preparations